PRTN3 and rheumatoid arthritis: Anti-citrullinated protein antibody-negative (ACPA-negative) RA comprises up to one-third of patients with RA, whereas lack of biomarkers in ACPA-negative RA poses a big challenge to early diagnosis (132).